ENERTECK CORP

2023 Q3 Form 10-Q Financial Statement

#000147793223006029 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.440K $24.28K $37.74K
YoY Change 289.19% -35.67% -42.44%
Cash & Equivalents $1.440K $24.28K $37.74K
Short-Term Investments
Other Short-Term Assets $31.12K $49.02K $50.28K
YoY Change -2.48% -2.51% -11.49%
Inventory $182.6K $184.3K $186.7K
Prepaid Expenses $31.12K $49.02K $50.28K
Receivables $8.393K $2.750K $7.540K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $223.6K $260.4K $282.3K
YoY Change -6.74% -7.76% 32.81%
LONG-TERM ASSETS
Property, Plant & Equipment $6.225K $6.241K $1.081K
YoY Change -1.02% 477.34% -11.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $37.52K
YoY Change 0.0%
Total Long-Term Assets $96.85K $99.99K $144.9K
YoY Change -34.09% -30.97% -8.02%
TOTAL ASSETS
Total Short-Term Assets $223.6K $260.4K $282.3K
Total Long-Term Assets $96.85K $99.99K $144.9K
Total Assets $320.4K $360.4K $427.1K
YoY Change -17.13% -15.63% 15.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $320.2K $318.3K $258.9K
YoY Change 21.31% 22.92% 0.67%
Accrued Expenses $344.1K $332.4K $2.244M
YoY Change 17.9% -85.19% 14.5%
Deferred Revenue
YoY Change
Short-Term Debt $4.473M $4.473M $3.893M
YoY Change 12.02% 14.9% 18.58%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.98M $12.80M $11.58M
YoY Change 9.72% 10.52% 11.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $12.98M $12.80M $11.58M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $12.98M $12.80M $11.58M
YoY Change 9.72% 10.52% 11.18%
SHAREHOLDERS EQUITY
Retained Earnings -$42.19M -$41.97M -$40.68M
YoY Change 2.97% 3.16% 2.96%
Common Stock $36.38K $36.38K $36.38K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$12.66M -$12.44M -$11.15M
YoY Change
Total Liabilities & Shareholders Equity $320.4K $360.4K $427.1K
YoY Change -17.13% -15.63% 15.43%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
50000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
269274 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21278 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
33728 usd
us-gaap Gross Profit
GrossProfit
4515 usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
2750 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
332372 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
301103 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
36381 usd
us-gaap Revenues
Revenues
76060 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11161 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
985 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
4515 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-489917 usd
us-gaap Interest Paid
InterestPaid
0 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1035 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
6950 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
314811 usd
CY2022Q2 us-gaap Revenues
Revenues
44889 usd
us-gaap Revenues
Revenues
5500 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
985 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001128353
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36380690 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36380690 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36380690 shares
CY2023Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
etck Stock Issued During Period Shares Stock Options Granted
StockIssuedDuringPeriodSharesStockOptionsGranted
0
etck Stock Issued During Period Shares Stock Options Exerciseds
StockIssuedDuringPeriodSharesStockOptionsExerciseds
0 shares
etck Stock Issued During Period Shares Stock Options Forfeited
StockIssuedDuringPeriodSharesStockOptionsForfeited
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
etck Share Based Compensation Arrangement By Share Based Payment Award Options For Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForExercisedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
etck Weighted Average Fair Value Grant Date Expired
WeightedAverageFairValueGrantDateExpired
0
etck Weighted Average Fair Value Grant Date Exercised
WeightedAverageFairValueGrantDateExercised
0
etck Weighted Average Fair Value Grant Date Forfeited
WeightedAverageFairValueGrantDateForfeited
0
etck Weighted Average Fair Value Grant Dategranted
WeightedAverageFairValueGrantDategranted
0
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
0 usd
CY2022Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-31981
dei Entity Registrant Name
EntityRegistrantName
ENERTECK CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0929885
dei Entity Address Address Line1
EntityAddressAddressLine1
10701 Corporate Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
dei Entity Address City Or Town
EntityAddressCityOrTown
Stafford
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77477
dei City Area Code
CityAreaCode
281
dei Local Phone Number
LocalPhoneNumber
240-1787
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36380690 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24278 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
56250 usd
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
93750 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
100000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
269306 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6241 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6273 usd
CY2023Q2 us-gaap Assets
Assets
360368 usd
CY2022Q4 us-gaap Assets
Assets
314811 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
318290 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
276876 usd
CY2023Q2 etck Customer Advances
CustomerAdvances
50900 usd
CY2022Q4 etck Customer Advances
CustomerAdvances
50900 usd
CY2023Q2 etck Related Parties Notes Advances Current
RelatedPartiesNotesAdvancesCurrent
4472500 usd
CY2022Q4 etck Related Parties Notes Advances Current
RelatedPartiesNotesAdvancesCurrent
4112500 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5067812 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4963987 usd
CY2023Q2 etck Accrued Interest Current
AccruedInterestCurrent
2554886 usd
CY2022Q4 etck Accrued Interest Current
AccruedInterestCurrent
2397780 usd
CY2023Q2 us-gaap Liabilities
Liabilities
12796760 usd
CY2022Q4 us-gaap Liabilities
Liabilities
12103146 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36380690 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
36381 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29495837 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29495837 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41968610 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41320553 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12436392 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11788335 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
360368 usd
CY2023Q2 us-gaap Revenues
Revenues
5500 usd
us-gaap Gross Profit
GrossProfit
54782 usd
CY2023Q2 us-gaap Salaries And Wages
SalariesAndWages
133978 usd
CY2022Q2 us-gaap Salaries And Wages
SalariesAndWages
133968 usd
us-gaap Salaries And Wages
SalariesAndWages
268006 usd
us-gaap Salaries And Wages
SalariesAndWages
268008 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3141 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3141 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6282 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6282 usd
CY2023Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
112955 usd
CY2022Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
91142 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
220144 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
203262 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
250074 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
228251 usd
us-gaap Operating Expenses
OperatingExpenses
494432 usd
us-gaap Operating Expenses
OperatingExpenses
477552 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-245559 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-194523 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-422770 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
4 usd
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
1 usd
us-gaap Interest Income Other
InterestIncomeOther
7 usd
us-gaap Interest Income Other
InterestIncomeOther
2 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-446 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1041 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2372 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
79604 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
73899 usd
us-gaap Interest Expense
InterestExpense
157106 usd
us-gaap Interest Expense
InterestExpense
145265 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-325605 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-268421 usd
us-gaap Net Income Loss
NetIncomeLoss
-648057 usd
us-gaap Net Income Loss
NetIncomeLoss
-565661 usd
CY2023Q2 etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
CY2022Q2 etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.02
etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.02
CY2023Q2 etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
CY2022Q2 etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-10585987 usd
us-gaap Net Income Loss
NetIncomeLoss
-565661 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-11151648 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11788335 usd
us-gaap Net Income Loss
NetIncomeLoss
-648057 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12436392 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-10883227 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-268421 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-11151648 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-12110787 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12436392 usd
us-gaap Profit Loss
ProfitLoss
-648057 usd
us-gaap Profit Loss
ProfitLoss
-565661 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6282 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6282 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4200 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7539 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
985 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-107018 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-33781 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-35558 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
65593 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
67475 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
157106 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
144412 usd
etck Accrued Compensation
AccruedCompensation
103825 usd
etck Accrued Compensation
AccruedCompensation
107650 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
31269 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
22759 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-695 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-312578 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-367893 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
0 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
etck Financed Portion Of Prepaid Insurance
FinancedPortionOfPrepaidInsurance
0 usd
etck Financed Portion Of Prepaid Insurance
FinancedPortionOfPrepaidInsurance
0 usd
us-gaap Payments For Reinsurance
PaymentsForReinsurance
24179 usd
us-gaap Payments For Reinsurance
PaymentsForReinsurance
17995 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
360000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
400000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
335821 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
382005 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
23243 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
14112 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1035 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23625 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24278 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37737 usd
us-gaap Interest Paid
InterestPaid
576 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
51571 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46293 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">EnerTeck Corporation, a Delaware corporation, and its wholly owned subsidiary, EnerTeck Chemical Corp. (“EnerTeck Sub”) (collectively referred to as the “Company”) are headquartered in Houston, Texas. The Company specializes in the sales, marketing and manufacture of a fuel borne catalytic engine treatment for diesel engines known as EnerBurn®. The use of EnerBurn in diesel engines improves fuel economy, lowers smoke, and decreases engine wear and the dangerous emissions of both Nitrogen Oxide (NOx) and microscopic airborne solid matter (particulates). Principal target markets have included the trucking, heavy construction, maritime shipping, railroad and mining industries, as well as federal, state and international government applications. Key uncertainties and risks to the Company include, but are not limited to, if and how quickly the EnerBurn technology is accepted by the market and the effects future technological changes and environmental regulatory requirements may have on the need for diesel fuel additives.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In preparing the accompanying interim unaudited condensed consolidated financial statements, management has made certain estimates and assumptions that affect reported amounts in the interim unaudited condensed consolidated financial statements and disclosures of contingencies. Actual results may differ from those estimates.</p>
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4940000 shares
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
4940000 shares
us-gaap Production Costs
ProductionCosts
78000 usd
CY2022 us-gaap Production Costs
ProductionCosts
79000 usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
2750 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
6950 usd
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6722 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6722 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3125 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3125 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6250 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6250 usd
CY2022Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
695 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0 usd
CY2023Q2 us-gaap Revenues
Revenues
5500 usd
CY2022Q2 us-gaap Revenues
Revenues
44889 usd
us-gaap Revenues
Revenues
5500 usd
us-gaap Revenues
Revenues
76060 usd
us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cost of goods sold includes costs related to the manufacture of the Company’s product EnerBurn. The primary costs included are raw materials that are mixed to produce the finished product that is then sold to customers and/or distributors. Other costs included are packaging and freight.</p>
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-325605 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-268421 usd
us-gaap Net Income Loss
NetIncomeLoss
-648057 usd
us-gaap Net Income Loss
NetIncomeLoss
-565661 usd
CY2023Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
30909 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
30909 usd
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
244638 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
244638 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
275547 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
275547 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
269306 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
269274 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6241 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6273 usd
CY2023Q2 us-gaap Depreciation
Depreciation
16 usd
CY2022Q2 us-gaap Depreciation
Depreciation
16 usd
us-gaap Depreciation
Depreciation
32 usd
us-gaap Depreciation
Depreciation
32 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-325605 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-268421 usd
us-gaap Net Income Loss
NetIncomeLoss
-648057 usd
us-gaap Net Income Loss
NetIncomeLoss
-565661 usd
CY2023Q2 etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
CY2022Q2 etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
etck Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
36380690 shares
CY2023Q2 etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
CY2022Q2 etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.02
etck Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.02
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.32
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1235070 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.32
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1235070 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y9M21D
CY2023Q2 etck Sharebased Compensation Arrangement By Sharebased Payment Award Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardNonvestedWeightedAverageGrantDateFairValue
0.09
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.32
etck Vested And Exercisable
VestedAndExercisable
1235070 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P1Y9M21D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.09
CY2009Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
100000 usd
CY2009Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.12 pure
CY2013Q4 us-gaap Proceeds From Grantors
ProceedsFromGrantors
1000000.0 usd
CY2023Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
0 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
0 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
14416 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
14283 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
28700 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
28567 usd

Files In Submission

Name View Source Status
0001477932-23-006029-index-headers.html Edgar Link pending
0001477932-23-006029-index.html Edgar Link pending
0001477932-23-006029.txt Edgar Link pending
0001477932-23-006029-xbrl.zip Edgar Link pending
etck-20230630.xsd Edgar Link pending
etck-20230630_cal.xml Edgar Link unprocessable
etck-20230630_def.xml Edgar Link unprocessable
etck_10q.htm Edgar Link pending
etck_ex311.htm Edgar Link pending
etck_ex312.htm Edgar Link pending
etck_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
etck-20230630_pre.xml Edgar Link unprocessable
etck-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
etck_10q_htm.xml Edgar Link completed